Document is current
Any future updates will be listed below
-
Authors
Smits, Lisa
Magni, Stefano
Grzyb, Kamil
Nickels, Sarah L.
Woods, Georgia
Muwanigwa, Mudiwa N.
Kurniawan, Henry
Cora, Virginia
Lu-Yang, Nika
Antony, Paul M. A.
Zagare, Alise
Krüger, Rejko
Andersen, Julie K.
Glaab, Enrico
Skupin, Alexander
Schwamborn, Jens C.
Bolognin, Silvia
-
Funding
Funding for this research was provided by:
Fonds National de la Recherche Luxembourg
Health~Holland
Starting Grant FHML
- License Information
-
More Information
Article History
Received: 4 September 2025
Accepted: 2 July 2026
First Online: 5 August 2026
Ethics
Competing interests: Silvia Bolognin and Jens C. Schwamborn are co-founders and shareholders of the spin-off company from the University of Luxembourg, OrganoTherapeutics. They are also co-inventors on a patent covering the generation of the here-described midbrain organoids (WO2017060884A1).
